CSPG4+ MTEX captured from the plasma of melanoma patients are highly enriched in melanoma-associated antigens (MAA) in comparison to CSPG4(-) non-MTEX, including CSPG4, TYRP2, MelanA, Gp100, VLA4. Here, PMEL is linked to melanoma.